N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.
Status:
Recruiting
Trial end date:
2023-05-21
Target enrollment:
Participant gender:
Summary
This study will evaluate the use of N-acetyl cysteine in post-reperfusion pulmonary injury in
patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary balloon
angioplasty and pulmonary endarterectomy. Half of the patients will receive N-acetyl cysteine
and the other placebo.